Atlanta, GA - November 6, 2025 – Marc-André Cornier, MD, FTOS, President of The Obesity Society (TOS), the nation’s leading scientific organization dedicated to advancing the understanding, prevention, and treatment of obesity, released the following statement on the White House’s agreement with major pharmaceutical companies to lower costs and expand access to FDA-approved obesity medications for Medicare beneficiaries. “The Obesity Society (TOS) welcomes the Administration’s announcement to lower the cost of FDA-approved obesity medications and increase access for individuals living with obesity. While the details of eligibility and implementation will determine the full impact, this initiative represents significant progress [...]

Media invited to attend virtually or in person for the latest on GLP-1 therapies, food policy, and obesity treatment reform ATLANTA, GA - October 14, 2025 — ObesityWeek 2025, hosted by The Obesity Society (TOS), returns to Atlanta from November 4–7, offering journalists a front-row seat, virtually or in person, to the most important conversations in obesity research, treatment, and policy. From the global GLP-1 revolution to the debates over food access, regulation, and healthcare equity, this year’s program brings together the world’s leading scientists, clinicians, and policymakers to explore how obesity is being reshaped across science, society, and [...]

Atlanta, GA - October 7, 2025 – Who decides what we eat, how we pay for care, and whether obesity is treated as a disease or a personal choice? At ObesityWeek® 2025, hosted by The Obesity Society (TOS) from November 4–7 in Atlanta, leading scientists, policymakers, and advocates will go head-to-head on the most divisive questions shaping obesity treatment and prevention in America. Under the banner “Policy, Economics, and Societal Controversy,” this powerhouse track dives into the political, ethical, and financial forces driving how obesity is understood and misunderstood, across science, government, and the public sphere. These sessions promise [...]

Atlanta, GA - September 19, 2025 – GLP-1 therapies are reshaping clinical practice, health policy, economics, and patient expectations. At ObesityWeek® 2025, hosted by The Obesity Society (TOS) in Atlanta from November 4–7, media will have the chance to move beyond the hype and gain direct access to the science, debates, and future direction of obesity treatment through a series of highly anticipated sessions on “The GLP-1 Revolution: Efficacy, Safety, and the Future of Treatment.” These sessions tackle the most significant breakthroughs and public concerns surrounding this new class of weight-loss medications. Drugs such as semaglutide and tirzepatide have dominated [...]

Atlanta – The Obesity Society (TOS) is pleased to invite credentialed media to attend ObesityWeek® 2025, the world’s preeminent scientific conference on obesity research, treatment and policy. The conference will be held November 4–7, 2025, in Atlanta, Georgia, bringing together leading researchers, clinicians, policymakers and advocates from around the world. Registration is free for credentialed journalists, and media attendees will enjoy a comprehensive suite of benefits designed to support high-impact storytelling and provide unparalleled access to leaders in the field. Exclusive Media Benefits Dedicated press room and resources: Access to a fully equipped press room, robust media kits and [...]

The Obesity Society joined the Academy of Nutrition and Dietetics and 13 other national health organizations in supporting United States medical schools to increase the number of hours devoted to nutrition education in medical training. Chronic lifestyle-related diseases such as diabetes, obesity, cardiovascular disease and malnutrition continue to strain families and health care systems. Yet most physicians receive fewer than 20 hours of nutrition instruction across four years of medical school. This is far short of what is needed to prepare them to meet today’s public health challenges. Expanding nutrition education will ensure that physicians: Understand the role of [...]

Acclaimed Obesity Expert and Seasoned Professionals Join Society Staff ROCKVILLE, MD – The Obesity Society (TOS), the leading organization of scientists and health professionals devoted to understanding and reversing the epidemic of obesity, is pleased to announce the addition of new staff members to its leadership team, enhancing its commitment to addressing obesity through innovative strategies and expert guidance. Under the leadership of its new CEO, Sherlyn Celone-Arnold, M.S., the organization is poised to strengthen its operational, research, and clinical initiatives. “I am excited about the depth and breadth of experience and innovative solutions these new team members bring [...]

Calls Grow for Immediate Enforcement as Unapproved Knockoffs Flood Market WASHINGTON, D.C. — July 22, 2025: A new report from The Center for Medicine in the Public Interest (CMPI) warns that regulators are failing to stop the illegal mass production of compounded GLP-1 drugs despite mounting evidence of patient harm and urges the U.S. Food and Drug Administration (FDA) to use its enforcement powers to end GLP-1 mass compounding practices to protect patients. The report, “FDA Regulatory Failures in Enforcing Limits on GLP-1 Compounding,” authored by CMPI President and former FDA Associate Commissioner Peter J. Pitts, documents how mass [...]

Sherlyn Celone-Arnold assumes new role after successful run as Chief Strategy Officer ROCKVILLE, MD – The Obesity Society (TOS), the leading organization of scientists and health professionals devoted to understanding and reversing the epidemic of obesity, has announced Sherlyn Celone-Arnold, M.S., as its new CEO, following the retirement of her predecessor, Anthony Comuzzie, Ph.D., FTOS. Celone-Arnold has worked as a strategic partner to TOS since 2019 and joined the organization earlier this year as its first Chief Strategy Officer. Ms. Celone-Arnold has over 20 years of experience helping organizations become industry pacesetters by pioneering innovative business strategies, designing award-winning [...]

Evidence-based nutrition and lifestyle interventions enhance GLP-1 treatment outcomes for obesity, improving adherence, health gains, and long-term weight maintenance Washington, D.C. (May 30, 2025) – Four leading organizations in lifestyle medicine, obesity medicine, and nutrition—the American College of Lifestyle Medicine (ACLM), the American Society for Nutrition (ASN), the Obesity Medicine Association (OMA), and The Obesity Society (TOS)—have jointly released a clinical advisory titled “Nutritional Priorities to Support GLP-1 Therapy for Obesity.” Published across four peer-reviewed journals, this consensus-based guidance reflects an interdisciplinary collaboration to help clinicians support patients receiving GLP-1 receptor agonists for obesity care with evidence-based nutritional and [...]